US 10457676
Capsazepine analogs for the treatment of cancer and other proliferative diseases
granted A61KA61K31/155A61K31/165
Quick answer
US patent 10457676 (Capsazepine analogs for the treatment of cancer and other proliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/155, A61K31/165, A61K31/17, A61K31/4035